Multivariate analysis of risk factors for time to acute GVHD, chronic GVHD, and progression
. | Odds ratio . | Confidence interval . | P . |
|---|---|---|---|
| Acute GVHD | |||
| ATG dose | 0.37 | 0.21-0.65 | .0005 |
| Chronic GVHD | |||
| PBSC graft | 3.03 | 1.59-5.76 | .0007 |
| Disease progression or relapse | |||
| GVHD, whatever its form or grade | 0.44 | 0.24-0.82 | .009 |
. | Odds ratio . | Confidence interval . | P . |
|---|---|---|---|
| Acute GVHD | |||
| ATG dose | 0.37 | 0.21-0.65 | .0005 |
| Chronic GVHD | |||
| PBSC graft | 3.03 | 1.59-5.76 | .0007 |
| Disease progression or relapse | |||
| GVHD, whatever its form or grade | 0.44 | 0.24-0.82 | .009 |
Variables with P < .05 in univariate analysis were included in the multivariate analysis.